PCA
SHC icon

Pallas Capital Advisors’s Sotera Health SHC Stock Holding History

Pallas Capital Advisors’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,613
Closed -$334K – 628
2024
Q3 		$334K Buy
+21,613
New +$316K 0.01% 452

Other funds holding SHC

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
MC
MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Pallas Capital Advisors's SHC Position: Q4 2024 in Review

Pallas Capital Advisors sold out of Sotera Health (SHC) in Q4 2024, closing a stake of 21,613 shares — an estimated $334K sold.

Pallas Capital Advisors first reported a position in SHC in Q3 2024 and held it in 1 quarter. The position peaked at $334K in Q3 2024. 216 funds tracked by Wall St. Rank hold SHC as of Q4 2024.

  • Pallas Capital Advisors reported no remaining Sotera Health position as of Q4 2024 after selling out during the quarter.
  • Pallas Capital Advisors sold 21,613 Sotera Health shares in Q4 2024, an estimated $334K.
  • Pallas Capital Advisors first reported a position in Sotera Health in Q3 2024 and held it in 1 quarter.
  • Pallas Capital Advisors's Sotera Health position peaked at $334K in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Sotera Health as of Q4 2024.

Based on Pallas Capital Advisors's 13F filing for Q4 2024, filed 13 Jan 2025.